| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Medicine (Y.W., S.N., T.S., H.Z.E., W.C., B.P.H., D.D.B.), Endocrine Unit, Veterans Affairs Medical Center, and University of California, San Francisco, California 94121; and Mineralized Tissues Research Section (S.B.D.), Hospital for Special Surgery, New York, New York 10021
Address all correspondence and requests for reprints to: Daniel D. Bikle, M.D., Ph.D., Endocrine Unit (111N), Veterans Affairs Medical Center, 4150 Clement Street, San Francisco, California 94121. E-mail: daniel.bikle{at}ucsf.edu.
Although IGF-I has been identified as an important growth factor for the skeleton, the role of IGF-I on embryonic bone development remains unknown. Here we show that, in IGF-I-deficient (IGF-I/) mice, skeletal malformations, including short-limbed dwarfism, were evident at days post coitus (dpc) 14.5 to 18.5, accompanied by delays of mineralization in the spinal column, sternum, and fore paws. Reduced chondrocyte proliferation and increased chondrocyte apoptosis were identified in both the spinal ossification center and the growth plate of long bones. Abnormal chondrocyte differentiation and delayed initiation of mineralization was characterized by small size and fewer numbers of type X collagen expressing hypertrophic chondrocytes and lower osteocalcin expression. The Indian hedgehog-PTHrP feedback loop was altered; expression of Indian hedgehog was reduced in IGF-I/ mice in long bones and in the spine, whereas expression of PTHrP was increased. Our results indicate that IGF-I plays an important role in skeletal development by promoting chondrocyte proliferation and maturation while inhibiting apoptosis to form bones of appropriate size and strength.
This article has been cited by other articles:
![]() |
W. Chang, C. Tu, T.-H. Chen, D. Bikle, and D. Shoback The Extracellular Calcium-Sensing Receptor (CaSR) Is a Critical Modulator of Skeletal Development Sci. Signal., September 2, 2008; 1(35): ra1 - ra1. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. Govoni, J. E. Wergedal, L. Florin, P. Angel, D. J. Baylink, and S. Mohan Conditional Deletion of Insulin-Like Growth Factor-I in Collagen Type 1{alpha}2-Expressing Cells Results in Postnatal Lethality and a Dramatic Reduction in Bone Accretion Endocrinology, December 1, 2007; 148(12): 5706 - 5715. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Zimmermann, F. Kiefer, M. Prudenziati, C. Spiller, J. Hansen, T. Floss, W. Wurst, S. Minucci, and M. Gottlicher Reduced Body Size and Decreased Intestinal Tumor Rates in HDAC2-Mutant Mice Cancer Res., October 1, 2007; 67(19): 9047 - 9054. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. Govoni, S. K. Lee, Y.-S. Chung, R. R. Behringer, J. E. Wergedal, D. J. Baylink, and S. Mohan Disruption of insulin-like growth factor-I expression in type II{alpha}I collagen-expressing cells reduces bone length and width in mice Physiol Genomics, August 20, 2007; 30(3): 354 - 362. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |